P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc.
SystImmune Inc.
Takeda
Novartis
Incyte Corporation
Travera Inc
Marengo Therapeutics, Inc.
Xencor, Inc.